cGxP.wire https://validator.w3.org/feed/docs/rss2.html Novartis Coartem Baby Wins WHO Nod for Infant Malaria Johnson & Johnson IMAAVY Delivers 2-Year gMG Control Adagio Medical Reports Positive vCLAS Results for VT FDA Fast-Tracks Psychedelic Therapies for Mental Illness Novartis Itvisma Gains CHMP Boost for SMA Therapy Johnson & Johnson PERSIGMA Trial Advances AFib Care BrioHealth Strengthens MedTech Pipeline with FDA Approval CGBIO Wins FDA IDE for NOVOSIS PUTTY Spine Trial OrthoTrophix TPX-100 Shows Breakthrough in Knee OA Study Arrowhead Gains CHMP Nod for REDEMPLO in Rare Disease Abbott Showcases AFib Tech Breakthrough at HRS 2026 Amphista Targeted Glue Data Shows Tumor Regression Medtronic Affera Catheters Show Strong HRS 2026 Data Ascletis Advances ASC30 Phase II Trial in Diabetes Intellia Nears Phase 3 CRISPR Data in HAE Breakthrough Compass Therapeutics Nears Key Data for Tovecimig in BTC WuXi Biologics Chengdu Plant Set for GMP Biologics Output Mabwell 9MW2821 Advances to Phase III in TNBC Trial Cerapedics Expands PearlMatrix Access via Vizient Deal Anaxiom AVOS Device Shows Safe Early Obesity Results Telomir Acquires TELI to Secure Global Telomir-1 Rights AbbVie $1.4B Durham Campus to Boost US Drug Manufacturing Haemonetics VASCADE MVP XL Shows Superior Closure Sonorous Neurovascular Advances Care with BosCATH Approval Clinuvel Advances Vitiligo Phase 3 with EMA Support Sanofi Cenrifki Wins EU CHMP Boost for Progressive MS Kyowa Kirin, Kura Oncology Launch Ziftomenib AML Trial Regeneron Otarmeni Gene Therapy FDA Hearing Breakthrough FLEX Vessel Prep Shows Strong 12-Month Outcomes Novo Nordisk Oral Semaglutide Shows Pediatric Breakthrough Merck Partners with Google Cloud for $1B AI Platform Regeneron & Sanofi Secure FDA Approval for Dupixent in Pediatric CSU Dogwood Therapeutics Secures $100M Partnership for Antiviral Assets Atrium Therapeutics Earns $15M Milestone from Bristol Myers Squibb Philips Launches Bridge Plus for Critical Cardiac Safety RenovoRx Showcases TAMP Platform Data at ASCO 2026 Repertoire Immune Medicines Doses First Patient in Phase 1/2 Trial AstraZeneca’s Ultomiris Shows Phase 3 Breakthrough in IgAN Genentech Reports Strong Phase 3 Enspryng Data in MOGAD InVita HemaConnect 2.5 Boosts CGT Donor Recruitment Aspira Women’s Health Expands Lab to Advance ENDOinform Test Mozart Therapeutics Shows Disease-Modifying Potential in Phase 1 Trial Utepreva Secures FDA Clearance for Advanced Endometrial Sampler Biotia Validates AI-NGS Test for Accurate UTI Detection DemeRx Gains FDA IND Clearance for DMX-1001 in AUD Astrin Earns CAP for Breast Cancer Blood Test Launch Apotex Expands U.S. Portfolio via Cumberland Deal Cipla Strengthens Global Pharma Leadership and Access Philips Boosts Cancer Imaging with Rembra FDA Clearance Santhera Pharmaceuticals Gains EU Boost for AGAMREE Expansion